Janet Ogden

Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti‐myeloma activity <i>in vitro</i> and <i>in vivo</i>

Sun‐Young Kong, Mariateresa Fulciniti, Xianfeng Li et al. · British Journal of Haematology · 2010 · 125 citations · Full text

Combination of a MEK inhibitor, pimasertib (MSC1936369B), and a PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial.

Rebecca S. Heist, Leena Gandhi, Geoffrey I. Shapiro et al. · Journal of Clinical Oncology · 2013 · 28 citations

Tumor Biology, Dual Pi3k/mtor Inhibitor, Medicine +15

Intratumoral iron oxide nanoparticle hyperthermia and radiation cancer treatment

P. Jack Hoopes, R. R. Strawbridge, Ursula J. Gibson et al. · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 2007 · 16 citations · Full text

Assessment of intratumor non-antibody directed iron oxide nanoparticle hyperthermia cancer therapy and antibody directed IONP uptake in murine and human cells

P. Jack Hoopes, Jennifer A. Tate, Janet Ogden et al. · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 2009 · 14 citations · Full text

Comparison of iron oxide nanoparticle and waterbath hyperthermia cytotoxicity

Janet Ogden, Jennifer A. Tate, R. R. Strawbridge et al. · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · 2009 · 10 citations · Full text

Nanoparticles, Nanomedicine, Chemical Engineering +14